XML 45 R34.htm IDEA: XBRL DOCUMENT v3.21.2
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Summary of the Components of Total Stock-Based Compensation Expense The following table summarizes the components of total stock-based compensation expense included in the condensed consolidated statements of operations for the periods presented.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021202020212020
(In thousands)
Cost of revenues$2,915 $1,294 $4,957 $3,237 
Research and development10,999 4,248 22,215 9,430 
Sales and marketing15,472 3,952 24,344 9,504 
General and administrative17,568 4,905 25,594 12,043 
Total$46,954 $14,399 $77,110 $34,214 
Summary of Stock-Based Compensation Associated with Each Type of Award
The following table summarizes the various types of stock-based compensation expense for the periods presented.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021202020212020
(In thousands)
Stock options, RSUs, and PSUs$45,992 $13,781 $74,193 $32,415 
Employee stock purchase plan962 618 2,917 1,799 
Total$46,954 $14,399 $77,110 $34,214 
Summary of Stock Option Activity
The following is a summary of stock option activity.
Number of
Shares
Outstanding
Weighted-
Average
Exercise Price
per Share
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20202,532 $1.96 
Granted— — 
Exercised(225)1.98 $32,144 
Canceled(1)0.83 
Outstanding at September 30, 20212,306 $1.96 3.0$341,368 
Vested and expected to vest at September 30, 20212,306 $1.96 3.0$341,368 
Exercisable at September 30, 20212,296 $1.95 3.0$339,784 
(1)    The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise. The intrinsic value of options outstanding, vested and expected to vest, and exercisable as of September 30, 2021 is based on the closing price of the last trading day during the period ended September 30, 2021. The Company’s stock fair value used in this computation was $149.97 per share.
Summary of Stock Option Outstanding
The following table summarizes information about stock options outstanding at September 30, 2021.
Options OutstandingOptions Exercisable
Range of Exercise PricesNumber of
Shares
Weighted-
Average
Remaining
Life
Weighted-
Average
Exercise
Price
Number of
Shares
Weighted-
Average
Exercise
Price
(In thousands)(Years)(In thousands)
$0.70 —– $1.11
504 3.6$0.85 505 $0.85 
$1.29 —– $1.29
1,000 3.01.29 1,000 1.29 
$1.31 —– $1.31
556 2.51.31 556 1.31 
$1.39 —– $14.58
235 3.25.92 224 5.90 
$64.17 —– $64.17
11 5.664.17 11 64.17 
Total2,306 3.0$1.96 2,296 $1.95 
Summary of Restricted Stock Unit Activity
The following is a summary of RSU activity.
Number of
Shares
Outstanding
Weighted-
Average
Fair Value
per Share at
Grant Date
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 20203,588 $27.61 
Granted957 160.39 
Vested(1,525)16.82 $263,402 
Canceled(95)78.93 
Outstanding at September 30, 20212,925 $74.99 1.1$438,709 
Expected to vest at September 30, 20212,925 $74.99 1.1$438,709 
(1)    The intrinsic value of RSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of RSUs outstanding and expected to vest as of September 30, 2021 is based on the closing price of the last trading day during the period ended September 30, 2021. The Company’s stock fair value used in this computation was $149.97 per share.
Share-based Compensation, Performance Shares Award Outstanding Activity
The following is a summary of PSU activity.
Number of
Shares
Outstanding
Weighted-
Average
Fair Value
per Share at
Grant Date
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
(1)
(In thousands)(Years)(In thousands)
Outstanding at December 31, 2020494 $51.10 
Granted694 130.14 
Vested(494)59.19 $91,803 
Canceled(264)51.15 
Outstanding at September 30, 2021430 $168.67 0.4$64,526 
(1)    The intrinsic value of PSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of PSUs outstanding and expected to vest as of September 30, 2021 is based on the closing price of the last trading day during the period ended September 30, 2021. The Company’s stock fair value used in this computation was $149.97 per share.
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The following table presents the weighted-average grant date fair value of options granted for the periods presented and the assumptions used to estimate those values using a Black-Scholes option pricing model.
Three Months Ended
September 30,
Nine Months Ended
September 30,
2021202020212020
Weighted average grant date fair value******$38.45
Expected term (in years)******3.8
Expected volatility******86.4%
Annual risk-free rate of return******0.1%
Dividend yield******—%
**    No stock options were granted during the three and nine months ended September 30, 2021.